Dudediligence.

Fortrea Holdings Inc

FTRENASDAQ · Services-Medical Laboratories
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$674.9MSep ’24$697.0MDec ’24$651.3MMar ’25$710.3MJun ’25$701.3MSep ’25$660.5MDec ’25$636.5MMar ’26$678.2MJun ’26
Net income, by quarter
−$27.9MSep ’24−$61.2MDec ’24−$562.9MMar ’25−$374.9MJun ’25−$15.9MSep ’25−$35.3MDec ’25−$23.6MMar ’26−$13.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$3.06B$2.84B$2.84B$2.70B$2.72B
Operating income$114.3M$187.1M$32.0M−$161.9M−$872.6M
Net income$98.0M$186.2M−$25.2M−$328.5M−$989.0M
Operating cash flow$169.8M$82.7M$168.4M$262.8M$113.5M
Free cash flow$143.3M$28.3M$128.1M$237.3M$88.3M
Cash$94.6M$112.0M$108.6M$118.5M$174.6M
Debtnone on file$0.00$1.59B$1.12B$1.05B
Shares outstanding88.8M088.8M89.7M93.1M